Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a

Vinothkumar Rajamanickam,* Tao Yan,* Liangrong Wu, Yanni Zhao, Xiaohong Xu, Heping Zhu, Xi Chen, Meihong Wang, Zhoudi Liu, Zhiguo Liu, Guang Liang, Yi Wang Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, People’s Re...

Full description

Bibliographic Details
Main Authors: Rajamanickam V, Yan T, Wu L, Zhao Y, Xu X, Zhu H, Chen X, Wang M, Liu Z, Liang G, Wang Y
Format: Article
Language:English
Published: Dove Medical Press 2020-01-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/allylated-curcumin-analog-ca6-inhibits-trxr1-and-leads-to-ros-dependen-peer-reviewed-article-CMAR
_version_ 1818217295593340928
author Rajamanickam V
Yan T
Wu L
Zhao Y
Xu X
Zhu H
Chen X
Wang M
Liu Z
Liu Z
Liang G
Wang Y
author_facet Rajamanickam V
Yan T
Wu L
Zhao Y
Xu X
Zhu H
Chen X
Wang M
Liu Z
Liu Z
Liang G
Wang Y
author_sort Rajamanickam V
collection DOAJ
description Vinothkumar Rajamanickam,* Tao Yan,* Liangrong Wu, Yanni Zhao, Xiaohong Xu, Heping Zhu, Xi Chen, Meihong Wang, Zhoudi Liu, Zhiguo Liu, Guang Liang, Yi Wang Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yi WangChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, People’s Republic of ChinaTel/Fax +86- 577-85773060Email yi.wang1122@wmu.edu.cnBackground: Gastric cancer is one of the leading causes of cancer-related deaths. Allylated monocarbonyl analogs of curcumin (MACs) have been reported to selectively inhibit a broad range of human cancers including gastric cancer. However, the precise molecular mechanisms underlying the inhibitory activities of MACs are not fully known.Methods: In this study, we examined the anti-tumor activities of an allylated MAC, CA6, on gastric cancer cells and gastric cancer xenograft mouse model. The potential molecular anti-tumor mechanisms of CA6 were also elucidated.Results: Our data show that CA6 exhibited significant cytotoxicity in gastric cancer cells, which was seen as an induction of G2/M cell cycle arrest and apoptosis. These activities were mediated through an elaboration of ROS levels in gastric cancer cells and induction of endoplasmic reticulum stress. CA6 increased ROS levels through directly binding to and inhibiting thioredoxin reductase R1 (TrxR1). Also, CA6-generated ROS inhibited Akt and activated forkhead O3A (FoxO3a), causing cytotoxicity in gastric cancer cells. Finally, CA6 treatment dose-dependently reduced the growth of gastric cancer xenografts in tumor-bearing mice, which was associated with reduced TrxR1 activity and increased ROS in the tumor.Conclusion: In summary, our studies demonstrate that CA6 inhibited gastric cancer growth by inhibiting TrxR1 and increasing ROS, which in turn activated FoxO3a through suppressing Akt. CA6 is a potential candidate for the treatment of gastric cancer.Keywords: gastric cancer, curcumin analog, reactive oxygen species, TrxR1, FOXO3a
first_indexed 2024-12-12T07:05:36Z
format Article
id doaj.art-8fe046d7e147413ca9b14ace1af37664
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-12T07:05:36Z
publishDate 2020-01-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-8fe046d7e147413ca9b14ace1af376642022-12-22T00:33:44ZengDove Medical PressCancer Management and Research1179-13222020-01-01Volume 1224726351089Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3aRajamanickam VYan TWu LZhao YXu XZhu HChen XWang MLiu ZLiu ZLiang GWang YVinothkumar Rajamanickam,* Tao Yan,* Liangrong Wu, Yanni Zhao, Xiaohong Xu, Heping Zhu, Xi Chen, Meihong Wang, Zhoudi Liu, Zhiguo Liu, Guang Liang, Yi Wang Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yi WangChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, People’s Republic of ChinaTel/Fax +86- 577-85773060Email yi.wang1122@wmu.edu.cnBackground: Gastric cancer is one of the leading causes of cancer-related deaths. Allylated monocarbonyl analogs of curcumin (MACs) have been reported to selectively inhibit a broad range of human cancers including gastric cancer. However, the precise molecular mechanisms underlying the inhibitory activities of MACs are not fully known.Methods: In this study, we examined the anti-tumor activities of an allylated MAC, CA6, on gastric cancer cells and gastric cancer xenograft mouse model. The potential molecular anti-tumor mechanisms of CA6 were also elucidated.Results: Our data show that CA6 exhibited significant cytotoxicity in gastric cancer cells, which was seen as an induction of G2/M cell cycle arrest and apoptosis. These activities were mediated through an elaboration of ROS levels in gastric cancer cells and induction of endoplasmic reticulum stress. CA6 increased ROS levels through directly binding to and inhibiting thioredoxin reductase R1 (TrxR1). Also, CA6-generated ROS inhibited Akt and activated forkhead O3A (FoxO3a), causing cytotoxicity in gastric cancer cells. Finally, CA6 treatment dose-dependently reduced the growth of gastric cancer xenografts in tumor-bearing mice, which was associated with reduced TrxR1 activity and increased ROS in the tumor.Conclusion: In summary, our studies demonstrate that CA6 inhibited gastric cancer growth by inhibiting TrxR1 and increasing ROS, which in turn activated FoxO3a through suppressing Akt. CA6 is a potential candidate for the treatment of gastric cancer.Keywords: gastric cancer, curcumin analog, reactive oxygen species, TrxR1, FOXO3ahttps://www.dovepress.com/allylated-curcumin-analog-ca6-inhibits-trxr1-and-leads-to-ros-dependen-peer-reviewed-article-CMARgastric cancercurcumin analogreactive oxygen speciestrxr1foxo3a
spellingShingle Rajamanickam V
Yan T
Wu L
Zhao Y
Xu X
Zhu H
Chen X
Wang M
Liu Z
Liu Z
Liang G
Wang Y
Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a
Cancer Management and Research
gastric cancer
curcumin analog
reactive oxygen species
trxr1
foxo3a
title Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a
title_full Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a
title_fullStr Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a
title_full_unstemmed Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a
title_short Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a
title_sort allylated curcumin analog ca6 inhibits trxr1 and leads to ros dependent apoptotic cell death in gastric cancer through akt foxo3a
topic gastric cancer
curcumin analog
reactive oxygen species
trxr1
foxo3a
url https://www.dovepress.com/allylated-curcumin-analog-ca6-inhibits-trxr1-and-leads-to-ros-dependen-peer-reviewed-article-CMAR
work_keys_str_mv AT rajamanickamv allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT yant allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT wul allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT zhaoy allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT xux allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT zhuh allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT chenx allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT wangm allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT liuz allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT liuz allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT liangg allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a
AT wangy allylatedcurcuminanalogca6inhibitstrxr1andleadstorosdependentapoptoticcelldeathingastriccancerthroughaktfoxo3a